Table 2 Adverse Events within 4 months

From: Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immunological correlates

 

Arm A (n = 10)

Arm B (n = 11)

Adverse Event

Grade 1-2 (%)

Grade 3-4 (%)

Grade 1-2 (%)

Grade 3-4 (%)

Altered Mental Status

0

0

0

1 (9.1)

Cerebral Edema

0

0

0

1 (9.1)

Cognitive Disturbance

1 (10.0)

0

0

0

Confusion

5 (50.0)

0

1 (9.1)

0

Dysarthria

1 (10.0)

0

0

0

Dysphasia

0

0

1 (9.1)

0

Facial Muscle Weakness

1 (10.0)

0

0

0

Fatigue

2 (20.0)

0

3 (27.3)

0

Gait Abnormality

0

0

1 (9.1)

0

Generalized Muscle Weakness

1 (10.0)

0

1 (9.1)

0

Headache

3 (30.0)

0

2 (18.2)

0

Paresthesia

0

0

1 (9.1)

0

Radiation Necrosis

0

0

1 (9.1)

0

Scalp Pain

1 (10.0)

0

0

0

Somnolence

2 (20.0)

0

0

0

Symptomatic

0

0

1 (9.1)

0

Tremor

0

0

1 (9.1)

0

Vision Changes

1 (10.0)

0

3 (27.3)

0